Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom Johnson who wrote (678)	1/9/1998 7:24:00 AM
From: Mr Logic	of 14101

>>Is anyone following this thread familiar with MacroChem Corp.?<< Yes, I am a stockholder in both Dimethaid & Macrochem. I have held long term and trading stock in Macrochem and currently have more than ever. The brief summary (disclaimer "as far as I am aware/can make out"): Well managed, working to a solid strategic plan No shortage of cash in the bank = no dilution Basic attractive technology being developed for a number of applications. Essentially SEPA enables large molecules to be absorbed through the skin (normally they aren't else we would all die). Pennsaid allows a topical application of an NSAID (non steroidal anti inflammatory drug), which is more effective that, say, taking Brufen orally. Macrochem's SEPA delivery of an NSAID would compete directly with Pennsaid. Macrochem's SEPA is applicable to a number of treatments - for example for treating Erectile Dysfunction, an established treatment is delivered, but via a cream rather than pellet or injection (ouch!). This is in late Phase II trials from memory. Happy with both these holdings at the moment. Patrick.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next